Inosine Pranobex (IP) - possibilities of its use in the treatment of COVID19
Article Sidebar
Main Article Content
Downloads
Article Details
Copyright (c) 2020 Dluholucký S.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine-Deaminase Deficiency in Two Patients with Severely Impaired Cellular Immunity. Lancet 2: 1067-1069. Link: https://bit.ly/3bcunO3
Johnson SM, North ME, Asherson GL, Allsop J, Watts RWE, et al. (1977) Lymphocyte Purine 5´-nucleotidase Deficiency in Primary Hypogammaglobulinemia. Lancet 1: 168-170.
Edwards NL, Magilavy DE, Cassidy JT, Fox LH (1978) Lymphocyte Ecto-5´-Nucleotidase Deficiency in Agammaglobulinaemia. Science 201: 628-630. Link: https://bit.ly/3gRbroZ
Pecháň I (1984) Relationship between immunodeficiencies and disorders of purine metabolism. BLL 81: 251-227. Link: https://bit.ly/3bbUJ2E
Pechan I, Rendekova V, Niks M, Pechanova E, Krizko J (1984) Adenosine- Deaminase and 5ase-Nucleotidase Activity of T-, and B-Lympgocytes of Human Peripheral Blood. Biologia / Bratislava 39: 381-386.
Dluholucký S, Pecháň I, Šváč J, Pecháňová E, Rajčanová V (1984) Activities of purine metabolism enzymes in children with IgA deficiency. Proceedings of the Czechoslovak Academy of Sciences Immunological Methods 95-99.
Dluholucký S, Pecháň I, Šváč J, Pecháňová E (1984) Activities of purine metabolism enzymes in healthy children and with IgA deficiency. ČSFR - German Pedagogical Symposium Liberec.
Pecháň I, Rendeková V, Dluholucký S, Svrčková E (1981) The role of adenosine metabolism in lymphoid cells. II. Nationwide congress Čs.spol. for allergology and clinical immunology. X. Stredo - Slovak days B. Bystrica.
Bornemisová A, Dluholucký S, Michálek J, Oslanec J (1984) Isoprinosine in the treatment of intraocular inflammation. Optalmological National Congress. Olomouc.
Dluholucký S, Bubanská E, Husáková K, StančokováT (1988) Immunomodulators in the treatment of varicella-zoster infections in pediatric malignancies. Days of Pediatric Oncology, Banská Bystrica.
Majewska A, Lasek W, Jsanyst M, Mlynarczyk G (2015) Inhibition of adenovirus multiplication by inosine pranobex and interferon alpha in vitro. Centr Eur J Immunol 40: 395-399. Link: https://bit.ly/3hMmnWr
Sliva J, Pantzartzi CN, Votava M (2019) Inosine Pranobex: A Key Player in the Gama Against a Wide Range of Viral Infections and Non-Infectious Diseases. Adv Ther 36: 1878-1905. Link: https://bit.ly/3lyyFnA
Haskó G, Sitkovsky MV, Szabó C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends in Pharm Sci 25: 152-157. Link: https://bit.ly/34SDP7R